Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas., PMID:39908567
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas., PMID:39908567
EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma., PMID:39695702
EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma., PMID:39695702
Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy., PMID:39211169
Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy., PMID:39211169
A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations., PMID:38995124
A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations., PMID:38995124
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma., PMID:38276183
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma., PMID:38276183
Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness., PMID:38254830
Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness., PMID:38254830
CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy., PMID:38211650
CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy., PMID:38211650
LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells., PMID:38169736
LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells., PMID:38169736
Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus., PMID:38146370
Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus., PMID:38146370
Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells., PMID:37876925
Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells., PMID:37876925
Molecular detection of Epstein-Barr virus among Sudanese patients diagnosed with Hashimoto's thyroiditis., PMID:37858193
Molecular detection of Epstein-Barr virus among Sudanese patients diagnosed with Hashimoto's thyroiditis., PMID:37858193
Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein., PMID:37512884
Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein., PMID:37512884
Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma., PMID:37508413
Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma., PMID:37508413
Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas., PMID:37426645
Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas., PMID:37426645
Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma., PMID:37373272
Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma., PMID:37373272
Epstein-Barr virus in breast carcinoma and in triple negative cases impact on clinical outcomes., PMID:37116366
Epstein-Barr virus in breast carcinoma and in triple negative cases impact on clinical outcomes., PMID:37116366
Epstein-Barr Virus-Positive Leiomyosarcoma in Immunocompetent Patients., PMID:36951222
Epstein-Barr Virus-Positive Leiomyosarcoma in Immunocompetent Patients., PMID:36951222
Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus., PMID:36782252
Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus., PMID:36782252
Association of human papillomavirus and Epstein-Barr virus with squamous cell carcinoma of upper aerodigestive tract., PMID:36683943
Association of human papillomavirus and Epstein-Barr virus with squamous cell carcinoma of upper aerodigestive tract., PMID:36683943
PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis., PMID:36326378
PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis., PMID:36326378
Incidence of Epstein-Barr Virus Among Women With Breast Cancer Using Monoclonal Antibodies for Latent Membrane Protein 1 (LMP1)., PMID:35478129
Incidence of Epstein-Barr Virus Among Women With Breast Cancer Using Monoclonal Antibodies for Latent Membrane Protein 1 (LMP1)., PMID:35478129
Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis., PMID:34790199
Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis., PMID:34790199
Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response., PMID:34728343
Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response., PMID:34728343
Uncovering early events in primary Epstein-Barr virus infection using a rabbit model., PMID:34707156
Uncovering early events in primary Epstein-Barr virus infection using a rabbit model., PMID:34707156
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases., PMID:34691042
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases., PMID:34691042
Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations., PMID:34612761
Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations., PMID:34612761
Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma., PMID:34546798
Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma., PMID:34546798
Updating targets for natural killer/T-cell lymphoma immunotherapy., PMID:33628584
Updating targets for natural killer/T-cell lymphoma immunotherapy., PMID:33628584
Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity., PMID:33613527
Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity., PMID:33613527
Selection of new immunotherapy targets for NK/T cell lymphoma., PMID:33312349
Selection of new immunotherapy targets for NK/T cell lymphoma., PMID:33312349
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma., PMID:33067267
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma., PMID:33067267
Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection., PMID:32343232
Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection., PMID:32343232
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis., PMID:32333154
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis., PMID:32333154
[Expression of LMP-1 protein in tumor cells and glandular epithelium of the peritumoral tissue in gastric cancer]., PMID:31851189
[Expression of LMP-1 protein in tumor cells and glandular epithelium of the peritumoral tissue in gastric cancer]., PMID:31851189
CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo., PMID:31807014
CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo., PMID:31807014
Construction of Epstein-Bar virus cocktail peptide fused with Fcγ of IgG: as a potential delivery system for vaccine development., PMID:31739735
Construction of Epstein-Bar virus cocktail peptide fused with Fcγ of IgG: as a potential delivery system for vaccine development., PMID:31739735
Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma., PMID:31618442
Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma., PMID:31618442
Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection., PMID:31360295
Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection., PMID:31360295
Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma., PMID:31063269
Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma., PMID:31063269
Fibronectin promotes nasopharyngeal cancer cell motility and proliferation., PMID:30551431
Fibronectin promotes nasopharyngeal cancer cell motility and proliferation., PMID:30551431
Epstein Barr Virus in Patients with Nephropathy Associated with Systemic Lupus Erythematous, Pilot Study in Egyptian Patients., PMID:30242993
Epstein Barr Virus in Patients with Nephropathy Associated with Systemic Lupus Erythematous, Pilot Study in Egyptian Patients., PMID:30242993
Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1., PMID:30137504
Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1., PMID:30137504
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas., PMID:29946193
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas., PMID:29946193
Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma., PMID:29761078
Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma., PMID:29761078
The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China., PMID:29606628
The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China., PMID:29606628
The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus., PMID:29497417
The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus., PMID:29497417
Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus., PMID:29338588
Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus., PMID:29338588
The potential of currently unavailable herpes virus vaccines., PMID:29313728
The potential of currently unavailable herpes virus vaccines., PMID:29313728
Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar., PMID:29228016
Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar., PMID:29228016
Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein-Barr Virus Latent Phase Protein LMP1., PMID:29063322
Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein-Barr Virus Latent Phase Protein LMP1., PMID:29063322
For research use only. Not for human or drug use.
